Obsessive-Compulsive Disorder (OCD) is characterized by uncontrollable, intrusive and recurring thoughts (obsessions), resulting in repetitive behaviours (compulsions). Migraine is a debilitating neurovascular disorder characterized by recurrent throbbing one-sided headache. Several investigations suggest that both OCD and migraine are associated with serotonergic dysfunction. OCD: The Cortico-Striatal-Thalamic-Cortical loop (CSTC) is considered the most important brain circuit involved in the pathophysiology of OCD, wherein serotonin is the principal neurotransmitter involved. Serotonergic medications act on specific circuits of CSTC leading to increased synaptic serotonin levels, which in turn help in amelioration of various symptoms of OCD. Migraine: The serotonergic system present in the brainstem raphe nucleus has been most commonly attributed in migraine pathophysiology. Reduced brain 5-HT synthesis and, thereby, reduced 5-HT neurotransmission in migraineurs can dilate cranial blood vessels and initiate migraine. Triptans act as 5-HT1B/1D receptor agonists and mimic the role of serotonin in binding to its receptors in trigeminal nerve endings and blood vessels, leading to cranial vasoconstriction as well as decrease in the release of peptides like Calcitonin Gene-Related Peptide (CGRP) and substance P, which ultimately stops the headache. There is a possible association between migraine and OCD. More research is warranted in this area to confirm this association. Considering the common role of serotonin in both these pathologies, there is a room for research on novel pharmacotherapy which can simultaneously act on the serotonergic pathways implicated in the pathology of both the disorders.
Carmi L, Brakoulias V, Arush OB, Cohen H, Zohar J. A prospective clinical cohort-based study of the prevalence of OCD, obsessive compulsive and related disorders, and tics in families of patients with OCD. BMC Psychiatry 2022; 22(1): 190.
Singh A, Anjankar V, Sapkale B. Obsessive-Compulsive Disorder (OCD): A comprehensive review of diagnosis, comorbidities, and treatment approaches. Cureus 2023; 15(11): e48960.
Rustom A, Audi F, Al Samsam H, Nour R, Mursi AM, Mahmoud I. Migraine awareness, prevalence, triggers, and impact on university students: a cross-sectional study. Egyptian journal of neurology, psychiatry and neurosurgery 2022; 58(1): 1-7.
Khan J, Al Asoom LI, Al Sunni A, Rafique N, Latif R, Al Saif S, et al. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed Pharmacother 2021; 139: 111557.
Dinn WM, Dinn AA, Robbins NC, Harris CL. Migrane headache and obsessive-compulsive symptoms in a student sample. Bull Clin Psychopharmacol 2005; 15(4): 174-81.
Frimpong-Manson K, Ortiz YT, McMahon LR, Wilkerson JL. Advances in understanding migraine pathophysiology: A bench to bedside review of research insights and therapeutics. Front Mol Neurosci 2024; 17: 1355281.
Rege S. Obsessive compulsive disorder- neurobiology, diagnosis and treatment. [cited 2018]. Available from: https://psychscenehub.com/psychinsights/obsessive-compulsive-disorder-neurobiology-treatment/
Hamel E, Currents H. Serotonin and migraine: Biology and clinical implications. Cephalalgia 2007; 27(11): 1293-300.
Aggarwal M, Puri V, Puri S. Serotonin and CGRP in migraine. Ann Neurosci 2012; 19(2): 88-94.
Viudez-Martínez A, Torregrosa AB, Navarrete F, García-Gutiérrez MS. Understanding the biological relationship between migraine and depression. Biomolecules 2024; 14(2): 163.
Viticchi G, Falsetti L, Salvemini S, Bartolini M, Paolucci S, Buratti L, et al. Efficacy of onabotulinum toxin A on obsessive-compulsive traits in a population of chronic migraine patients. Brain Sci 2022; 12(11): 1563.
Deshmukh, A. (2025). Obsessive-compulsive disorder and migraine: The “serotonin” connection. Fundamentals of Mental Health, 27(6), 417-420. doi: 10.22038/JFMH.2025.86406.3221
MLA
Deshmukh, A. . "Obsessive-compulsive disorder and migraine: The “serotonin” connection", Fundamentals of Mental Health, 27, 6, 2025, 417-420. doi: 10.22038/JFMH.2025.86406.3221
HARVARD
Deshmukh, A. (2025). 'Obsessive-compulsive disorder and migraine: The “serotonin” connection', Fundamentals of Mental Health, 27(6), pp. 417-420. doi: 10.22038/JFMH.2025.86406.3221
CHICAGO
A. Deshmukh, "Obsessive-compulsive disorder and migraine: The “serotonin” connection," Fundamentals of Mental Health, 27 6 (2025): 417-420, doi: 10.22038/JFMH.2025.86406.3221
VANCOUVER
Deshmukh, A. Obsessive-compulsive disorder and migraine: The “serotonin” connection. Fundamentals of Mental Health, 2025; 27(6): 417-420. doi: 10.22038/JFMH.2025.86406.3221